Why Advar?
With the pharmaceutical market set to intensify both in terms of competitiveness and complexity Advar has been preparing to accommodate our clients future needs. We have accumulated the resources and the know-how to cover an increasingly broad part of our clients’ value chain.
W
We have prepared for a turn to next generation outsourcing with a focus on multi-service solutions as opposed to pure manufacturing, packaging and testing. We anticipate a continuously increasing process and supply chain complexity.
H
A key feature of next generation models is a shift towards a more closely integrated and synergistic working relationship. In practice this means that choosing the right partner is now more critical than ever.
Y
At Advar we have chosen to concentrate on pursuing a partnership approach with our clients by providing a one-stop-shop that offers strong support and added value throughout their value chains.
Industry Dynamics
CMO industry drivers
01. Cost saving
Optimization of plant utilization to improve cost efficiency
Benefit from CMO’s operational efficiency: competitive cost and improved margins
02. Refocusing of resources
Concentrate on core competencies such as developing new products, completing clinical trials and marketing
Gain access to technical expertise and capabilities
03. Freeing-up the asset base
Achieving more flexible and efficient use of capital by transferring fixed costs to variable costs
Increasing the ROI as a result of a reduced operating outlay
04. Supply chain flexibility and effectiveness
Expanding manufacturing footprint and securing proximity to markets
Managed demand volatility for existing products as well as NPIs
Advar's value proposition & competitive edge
At Advar we are very conscious of the growing needs of our client base. Yet, we remain committed to the principle that our first responsibility is to the patient. rather than considering Quality Assurance simply as a prerequisite which makes us eligible to offer our services, we view GMP excellence as our most important differentiator and long-term competitive advantage. In this sense, quality standards take precedence above everything else and serve as a guide for our growth prospects.
Advar is focused on delivering the best value for our customers, continuously removing waste from our manufacturing process and supply chain. Eliminating waste along entire value streams, instead of at isolated points, creates processes that need less human effort, less space, less capital, and less time to make products and services at far less costs and with much fewer defects, compared with traditional operating systems.
Advar’s 3rd strategic differentiator is a sustainably timely and accurate supply to market. We work with our partners to assure enhanced flexibility in responding to market demand fluctuations, higher flexibility, shorter lead times to trade, and shorter planning cycles while optimizing inventories throughout the chain.
Advar is in the process of building a one-stop-shop manufacturing platform for our clients. Our service package includes a broad range of services supporting our customer from drug discovery/pre-formulation to commercialization in more than 30 dosage forms.
Shareholders of Advar are in it for the long term. We believe both in the company’s as well as the industry’s immense potential.
Moreover, being a private company gives us the advantage of a very mindful and systematic balancing of short-term and long-term objectives in terms of results, process improvements as well as capital expenditure. We will always give precedence to our strategic objectives over quarterly results.
Advar has always been backed by a group that believes both in Advar’s vision as well as its industry’s potential.
Moreover, since its inception in 1943, Advar has sustained strong and steadily growing capital structure.
